Literature DB >> 9699144

Exceptional desiccation tolerance of Acinetobacter radioresistens.

A Jawad1, A M Snelling, J Heritage, P M Hawkey.   

Abstract

The taxonomy of the genus Acinetobacter, which includes several important nosocomial pathogens, has been confused due to a lack of discriminatory phenotypic characteristics for identification. Molecular methods such as amplified ribosomal DNA restriction analysis (ARDRA) now enable the accurate identification of species. Ten clinical isolates of Acinetobacter radioresistens had genospecies confirmed by ARDRA but the APJ 20NE system, commonly used in clinical microbiology laboratories, mis-identified them as Acinetobacter lwoffii. Desiccation resistance of Acinetobacter spp. is an important attribute for their survival in the clinical environment. We investigated the ability of A. radioresistens to survive desiccation using an established glass surface model and compared the results to A. lwoffii and Acinetobacter baumannii. The 10 strains of A. radioresistens were extremely resistant to desiccation and survived for an average of 157 days at 31% relative humidity (RH). In contrast, two strains of A. lwoffii and three strains of A. baumannii survived for an average of three and 20 days respectively, at 31% RH, which was used as an approximation to climatic conditions in UK hospitals. A. radioresistens is thus well adapted for survival in the hospital environment and carriage on human skin and yet it is reported less frequently than A. lwoffii amongst clinical isolates. Cases of A. radioresistens infection may be under-reported due to mis-identification as A. lwoffii and further studies that use molecular identification methods are required to elucidate the role of A. radioresistens in human disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699144     DOI: 10.1016/s0195-6701(98)90263-8

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  19 in total

1.  Skin carriage of acinetobacters in Hong Kong.

Authors:  Y W Chu; C M Leung; E T Houang; K C Ng; C B Leung; H Y Leung; A F Cheng
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Gene transfer potential of outer membrane vesicles of Acinetobacter baylyi and effects of stress on vesiculation.

Authors:  Shweta Fulsundar; Klaus Harms; Gøril E Flaten; Pål J Johnsen; Balu Ananda Chopade; Kaare M Nielsen
Journal:  Appl Environ Microbiol       Date:  2014-03-21       Impact factor: 4.792

3.  Light Modulates Important Pathogenic Determinants and Virulence in ESKAPE Pathogens Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus.

Authors:  M R Tuttobene; J F Pérez; E S Pavesi; B Perez Mora; D Biancotti; P Cribb; M Altilio; G L Müller; H Gramajo; G Tamagno; M S Ramírez; L Diacovich; M A Mussi
Journal:  J Bacteriol       Date:  2021-02-08       Impact factor: 3.490

4.  Acinetobacter baumannii: An Emerging and Important Pathogen.

Authors:  Marcella Alsan; Michael Klompas
Journal:  J Clin Outcomes Manag       Date:  2010-08

5.  Hepatic hydrothorax: indwelling catheter-related Acinetobacter radioresistens infection.

Authors:  Cristiano Silva Cruz; Valentina Tosatto; Paula Oliveira Nascimento; Rita Barata Moura
Journal:  BMJ Case Rep       Date:  2019-03-15

6.  Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.

Authors:  Rebecca H Sunenshine; Marc-Oliver Wright; Lisa L Maragakis; Anthony D Harris; Xiaoyan Song; Joan Hebden; Sara E Cosgrove; Ashley Anderson; Jennifer Carnell; Daniel B Jernigan; David G Kleinbaum; Trish M Perl; Harold C Standiford; Arjun Srinivasan
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

7.  Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp.

Authors:  Laurent Poirel; Samy Figueiredo; Vincent Cattoir; Alessandra Carattoli; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-01-14       Impact factor: 5.191

Review 8.  Treatment options for multidrug-resistant Acinetobacter species.

Authors:  Jacob Gilad; Yehuda Carmeli
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  How long do nosocomial pathogens persist on inanimate surfaces? A systematic review.

Authors:  Axel Kramer; Ingeborg Schwebke; Günter Kampf
Journal:  BMC Infect Dis       Date:  2006-08-16       Impact factor: 3.090

10.  Evolution of a pathogen: a comparative genomics analysis identifies a genetic pathway to pathogenesis in Acinetobacter.

Authors:  Jason W Sahl; John D Gillece; James M Schupp; Victor G Waddell; Elizabeth M Driebe; David M Engelthaler; Paul Keim
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.